UPDATE: Piper Sandler Upgrades Milestone Pharmaceuticals (MIST) to Overweight
Tweet Send to a Friend
(Updated - April 22, 2022 6:14 AM EDT)
Piper Sandler analyst Edward Tenthoff upgraded Milestone Pharmaceuticals (NASDAQ: MIST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Edward Tenthoff upgraded Milestone Pharmaceuticals (NASDAQ: MIST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
